Cellarim Labs raises ₹6 crore to commercialise cell-free hyaluronic acid for Indian beauty brands
Bengaluru-based Cellarim Labs will use its seed round to build a pilot-scale facility and expand B2B supply of NeuHyal, its cell-free hyaluronic-acid range. The company is positioning local production as an alternative to imported cosmetic ingredients; the pilot plant is not yet operational.
What happened
Bengaluru-based Cellarim Labs raised ₹6 crore to build a pilot facility and commercialise NeuHyal, a cell-free manufactured hyaluronic-acid range. The B2B
Key facts
- ₹6 crore seed round
- approximately $830,000 total funding
- NeuHyal molecular-weight range: 10-5,000 kDa
- over 95% claimed yield
- 90% less water
- 95% fewer emissions
- 80% more economical than precision fermentation
Why this matters
Beauty and personal-care ingredient buyers may view Cellarim as an early strategic sourcing or partnership target, especially if its NeuHyal range can match imported materials on quality, consistency and cost.
What to watch
- Pilot plant commissioning date and evidence of repeatable batch production.
- Named B2B formulation partners, paid purchase orders or multi-year offtake agreements.
- Independent quality certifications and regulatory documentation suitable for cosmetic ingredient buyers.
- Reported production yield, cost per kilogram and ability to offer multiple molecular-weight grades.
- Any announced manufacturing or distribution alliance with Indian specialty-ingredient players.
- Follow-on fundraising before meaningful commercial revenue, which could signal capital intensity or delays.
- Beauty-brand shifts toward domestically sourced actives amid import-cost or supply-chain volatility.
- Commission the pilot-scale facility and publish a credible timeline for first commercial batches.
- Secure third-party purity, molecular-weight, microbiological and stability testing for NeuHyal grades.
- Run formulation and efficacy trials with Indian skincare, dermocosmetic and haircare brands.
- Build a distributor or contract-manufacturing partnership to reach formulators beyond direct sales.
- Use local production claims carefully, emphasizing traceability, lead-time reliability and application performance rather than import substitution alone.
- Prepare for a follow-on round if pilot commissioning, validation and working-capital needs exceed the ₹6 crore seed budget.